FDAnews
www.fdanews.com/articles/81452-gen-probe-says-fda-has-not-approved-test

GEN-PROBE SAYS FDA HAS NOT APPROVED TEST

October 6, 2005

Gen-Probe says regulators have not approved its Procleix Tigris system for screening human blood, and that clearance is not expected by the end of the year. Shares of Gen-Probe plunged $7.37, or 15.5 percent on the news, to $40.04 in aftermarket activity, after closing down 2.7 percent at $47.41 on the Nasdaq. Over the past 52 weeks, its stock has traded in a range of $31.52 to $53.14, and is down 11 percent year-to-date.

Yahoo News (http://biz.yahoo.com/ap/051005/gen_probe_fda.html?.v=1)